Health Outcomes in Rheumatoid Arthritis

This study is currently recruiting participants.

Verified by Johns Hopkins University, May 2006

Sponsored by:	Johns Hopkins University
Information provided by:	Johns Hopkins University
ClinicalTrials.gov Identifier:	NCT00346411

Purpose

This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.

Condition
Rheumatoid Arthritis

MedlinePlus related topics: Rheumatoid Arthritis

U.S. FDA Resources

Study Type:	Observational
Study Design:	Psychosocial, Longitudinal, Defined Population, Prospective Study
Official Title:	Health Outcomes in Rheumatoid Arthritis

Further study details as provided by Johns Hopkins University:

Estimated Enrollment:

260

Eligibility

Ages Eligible for Study:	19 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Males and females age 19 or older
Current active, adult-onset rheumatoid arthritis who meet ACR criteria for RA and have: (American College of Rheumatology [ACR] functional class I–III), defined as:
3 or more swollen or tender joints and
Morning stiffness of 45min or longer
OR judged by their rheumatologist to have active disease
No evidence of other inflammatory diseases (e.g., Crohn’s, IBS)
Functional class I, II or III

Exclusion Criteria:

Individuals with significant cardiovascular disease (CHF, stroke, MI)
Unwilling to have medications monitored and/or comply with protocol
Not fluent in English
Planning to move from area within next year or change health insurance (which would preclude ongoing care by JH rheumatologist)
Enrolled in study evaluating efficacy of new or existing RA medications

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00346411

Contacts

Contact: Steffany Haaz, MFA	(410) 550-5216	shaaz1@jhmi.edu
Contact: Susan Bartlett, PhD	(410) 550-7775	bartlett@jhmi.edu

Locations

United States, Maryland
Johns Hopkins Bayview Campus	Recruiting
Baltimore, Maryland, United States, 21224
Contact: Steffany Haaz, MFA 410-550-5216 shaaz1@jhmi.edu
Contact: Susan Bartlett, PhD (410) 550-7775 bartlett@jhmi.edu
Principal Investigator: Susan Bartlett, PhD
Good Samaritan Hospital	Recruiting
Baltimore, Maryland, United States, 21239
Contact: Clifford Bingham, MD 410-532-4646 clifton.bingham@JHMI.edu
Sub-Investigator: Clifford Bingham, MD

Sponsors and Collaborators

Johns Hopkins University

Investigators

Principal Investigator:	Susan Bartlett, PhD	Johns Hopkins School of Medicine
Study Director:	Steffany Haaz, MFA	Johns Hopkins University

More Information

Study ID Numbers:	NA_00001359
Study First Received:	June 28, 2006
Last Updated:	June 28, 2006
ClinicalTrials.gov Identifier:	NCT00346411
Health Authority:	United States: Institutional Review Board

Keywords provided by Johns Hopkins University:

rheumatoid arthritis
mood
adherence
medication

Study placed in the following topic categories:

Autoimmune Diseases
Musculoskeletal Diseases
Joint Diseases
Arthritis

Connective Tissue Diseases
Arthritis, Rheumatoid
Rheumatic Diseases

Additional relevant MeSH terms:

Immune System Diseases

ClinicalTrials.gov processed this record on January 14, 2009